secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2026-06-11T20:00:49+00:00
Accession:  0001171843-26-004068
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders re-elect Schuetz & Lindahl, ratify CohnReznick, approve exec compensation
--------------------------------------------------------------------------------

- Thomas J. Schuetz elected with 102,984,184 for, 18,837,499 withheld; Richard S. Lindahl with 103,453,540 for, 18,368,143 withheld.
- CohnReznick LLP ratified as independent auditor for FY 2026 (137,896,097 for, 181,037 against).
- Non-binding advisory vote on executive compensation approved (117,963,684 for, 1,796,022 against).
- Shareholders voted for annual say-on-pay frequency (118,289,260 for every year); board adopted annual frequency.
- All proposals passed with no surprises; broker non-votes reported for director elections and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000117184326004068/0001171843-26-004068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000117184326004068/f8k_061126.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-004068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer